[go: up one dir, main page]

AU2002227123A1 - Method of treatment with a combination of a pde4 inhibitor and a leukotriene antagonist - Google Patents

Method of treatment with a combination of a pde4 inhibitor and a leukotriene antagonist

Info

Publication number
AU2002227123A1
AU2002227123A1 AU2002227123A AU2712302A AU2002227123A1 AU 2002227123 A1 AU2002227123 A1 AU 2002227123A1 AU 2002227123 A AU2002227123 A AU 2002227123A AU 2712302 A AU2712302 A AU 2712302A AU 2002227123 A1 AU2002227123 A1 AU 2002227123A1
Authority
AU
Australia
Prior art keywords
treatment
combination
pde4 inhibitor
leukotriene antagonist
leukotriene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002227123A
Inventor
Yujun Chang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU2002227123A1 publication Critical patent/AU2002227123A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002227123A 2000-11-07 2001-11-02 Method of treatment with a combination of a pde4 inhibitor and a leukotriene antagonist Abandoned AU2002227123A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24636800P 2000-11-07 2000-11-07
US60246368 2000-11-07
PCT/US2001/045514 WO2002038155A1 (en) 2000-11-07 2001-11-02 Method of treatment with a combination of a pde4 inhibitor and a leukotriene antagonist

Publications (1)

Publication Number Publication Date
AU2002227123A1 true AU2002227123A1 (en) 2002-05-21

Family

ID=22930371

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002227123A Abandoned AU2002227123A1 (en) 2000-11-07 2001-11-02 Method of treatment with a combination of a pde4 inhibitor and a leukotriene antagonist

Country Status (4)

Country Link
US (1) US6528527B2 (en)
AU (1) AU2002227123A1 (en)
CA (1) CA2427814C (en)
WO (1) WO2002038155A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
JP2005528418A (en) * 2002-05-07 2005-09-22 アルタナ　ファルマ　アクチエンゲゼルシャフト Novel combinations for treating airway diseases
EP1511516B1 (en) * 2002-05-28 2008-12-17 Nycomed GmbH Topically applicable pharmaceutical preparation
CA2508692C (en) * 2002-12-12 2012-04-03 Altana Pharma Ag Combination medicament
WO2004087150A1 (en) * 2003-03-31 2004-10-14 Kyowa Hakko Kogyo Co. Ltd. Drug composition
US20050026886A1 (en) * 2003-07-29 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a PDE IV inhibitor
WO2005025578A1 (en) * 2003-09-16 2005-03-24 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases
JP2007533706A (en) * 2004-04-20 2007-11-22 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング Use of ciclesonide for the treatment of respiratory diseases in smoking patients
EP1791538A1 (en) * 2004-09-10 2007-06-06 Altana Pharma AG Roflumilast and syk inhibitor combination and methods of use thereof
US20100210611A1 (en) * 2007-10-25 2010-08-19 Roch Thibert Combination therapy
WO2012168907A1 (en) * 2011-06-10 2012-12-13 Glenmark Pharmaceuticals Sa Pharmaceutical composition comprising revamilast and montelukast or zafirlukast
WO2014012954A1 (en) 2012-07-18 2014-01-23 Takeda Gmbh Treatment of partly controlled or uncontrolled severe asthma
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof
US20160339010A1 (en) * 2014-01-22 2016-11-24 Takeda Gmbh Treatment of Partly Controlled or Uncontrolled Severe Asthma
GB202306663D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Combination therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565473A (en) * 1990-10-12 1996-10-15 Merck Frosst Canada, Inc. Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
PL178314B1 (en) * 1993-07-02 2000-04-28 Byk Gulden Lomberg Chem Fab Fluoroaloxyl-group substituted benzamides and their application as inhibitors of phosphodiesterase of cyclic nucleotides

Also Published As

Publication number Publication date
CA2427814A1 (en) 2002-05-16
CA2427814C (en) 2009-06-02
WO2002038155A1 (en) 2002-05-16
US20020055520A1 (en) 2002-05-09
US6528527B2 (en) 2003-03-04

Similar Documents

Publication Publication Date Title
AU2001282886A1 (en) Combination of a cox-2 inhibitor and a vasomodulator for treating pain and headache pain
PL359820A1 (en) Hmg-coa reductase inhibitors and method
AU2002324775A1 (en) Architecture tool and methods of use
AU2002314466A1 (en) Withasol and methods of use
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2002227123A1 (en) Method of treatment with a combination of a pde4 inhibitor and a leukotriene antagonist
AU2001269331A1 (en) Cleaning and doping of tubulars
AU2002223275A1 (en) A method of expression and agents identified thereby
AU2001248365A1 (en) 2-(arylalkylamino)pyrimidone derivatives and 2-(heteroarylalkylamino)pyrimidone derivatives
AU2001216218A1 (en) Heterocyclic analgesic compounds and method of use thereof
AU2002213346A1 (en) Osteopontin-coated surfaces and methods of use
AU2002337913A1 (en) Glycosulfopeptide inhibitors and methods of use thereof
AU2001288972A1 (en) Antipsychotic sulfonamide-heterocycles, and methods of use thereof
AU2002315225A1 (en) Fastener remover and method of use
AU2001232809A1 (en) Gyrase inhibitors and uses thereof
AU3270301A (en) Combined pde3 and pde4 inhibitor therapy for the treatment of obesity
PL363544A1 (en) Piperazino-derivatives and their use as pde4 inhibitor
AU2001255696A1 (en) Telomerase inhibitors and methods of their use
AU2002363938A1 (en) Methods and use of motoneuronotropic factors
AU2001261837A1 (en) Automatic configuration of equipment and software
AUPQ582400A0 (en) A method of treatment and agents for use therein
AU2001268236A1 (en) Use of aicar and related compounds
AU2001285136A1 (en) Pointing device cleaner and method of use
AU2002222125A1 (en) Prevention and treatment of tachyphylactic response
AUPQ592100A0 (en) A method of treatment and prophylaxis